Circulating biochemical markers of brain damage in infants complicated by ischemia reperfusion injury

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 7, Issue 2, 2009, Pages 108-126

  Gazzolo, Diego ^a,b   Abella, Raul ^c   Marioni, Emanuela ^d   Di Iorio, Romolo ^d   Li Volti, Giovanni ^e   Galvano, Fabio ^e   Ponginglione, Giacomo ^a   Frigiola, Alessandro ^c   Bertino, Enrico ^f   Florio, Pasquale ^g  

^a UNIVERSITY OF GENOA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

^c S Donato Milanese University Hospital   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

^g UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ADRENOMEDULLIN; BIOCHEMICAL MARKER; CYTOKINE; FREE RADICAL; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; NEUROTRANSMITTER; PROTEIN S100B; BIOLOGICAL MARKER; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

AIR EMBOLISM; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; DEEP HYPOTHERMIC CIRCULATORY ARREST; EXCITATION; HUMAN; IN VITRO STUDY; INFANT; INFANT DISEASE; INFLAMMATION; NEUROTRANSMITTER RELEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PERFUSION; PERINATAL ASPHYXIA; PEROPERATIVE COMPLICATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; ANIMAL; BLOOD;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT; NERVE GROWTH FACTORS; REPERFUSION INJURY; S100 PROTEINS;

EID: 67650573442     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152509787847119     Document Type: Review

References (236)

1. Volpe, J.J. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin. Pediatr. Neurol., 1998, 5, 135.
2. Ingebrigtsen, T.; Romner, B. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor. Neurol. Neurosci., 2003, 21, 171.
3. Hughes, P.E.; Alexi, T.; Walton, M.; Williams, C.E.; Dragunow, M.; Clark, R.G.; Gluckman, P.D. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog. Neurobiol., 1999, 57, 421.
4. Visser, G.H. Why does perinatal morbidity increase. J. Perinat. Med., 1994, 22(Suppl. 1), 28.
5. Hagberg, B.; Hagberg, G.; Olow, I.; von Wendt, L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr., 1996, 85, 954.
6. Botero, D.; Lifshitz, F. Intrauterine growth retardation and longterm effects on growth. Curr. Opin. Pediatr., 1999, 11, 340.
7. Inder, T.E.; Volpe, J.J. Mechanisms of perinatal brain injury. Semin. Neonatol., 2000, 5, 3.
8. Freeman, J.M.; Nelson, K.B. Intrapartum asphyxia and cerebral palsy. Pediatrics, 1988, 82, 240.
9. Hughes, I.; Newton, R. Genetic aspects of cerebral palsy. Dev. Med. Child Neurol. 1992, 34, 80.
10. Hagberg, B.; Hagberg, G.; Beckung, E.; Uvebrant, P. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-94. Acta Paediat., 2001, 90, 271.
11. Hsia, T.Y.; Gruber, P.J. Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control. Ann. Thorac. Surg., 2006, 81, S2381-S2388.
12. Levene, M.I.; Sands, C.; Grindulis, H.; Moore, J.R. Comparison of two methods of predicting outcome in perinatal asphyxia. Lancet 1986, 1, 67.
13. Ferry, P.C. Neurologic sequelae of cardiac surgery in children. Am. J. Dis. Child 1987, 141, 309.
14. Ferry, P.C. Neurologic sequelae of open-heart surgery in children. An 'irritating question'. Am. J. Dis. Child 1990, 144, 369.
15. Pua, H.L.; Bissonnette, B. Cerebral physiology in paediatric cardiopulmonary bypass. Can. J. Anaesth., 1998, 45, 960.
16. Newburger, J.W.; Jonas, R.A.; Wernovsky, G.; Wypij, D.; Hickey, P.R.; Kuban, K.C.; Farrell, D.M.; Holmes, G.L.; Helmers, S.L.; Constantinou, J. A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N. Engl. J. Med., 1993, 329, 1057.
17. Bergman, I.; Painter, M.J.; Hirsch, R.P.; Crumrine, P.K.; David, R. Outcome in neonates with convulsions treated in an intensive care unit. Ann. Neurol., 1983, 14, 642.
18. Miatton, M.; De Wolf, D.; Francois, K.; Thiery, E.; Vingerhoets, G. Neurocognitive consequences of surgically corrected congenital heart defects: a review. Neuropsychol. Rev., 2006, 16, 65.
19. Beckung, E.; Hagberg, G.; Uldall, P.; Cans, C. Probability of walking in children with cerebral palsy in Europe. Pediatrics, 2008, 121, e187-e192.
20. Alvarez-Diaz, A.; Hilario, E.; de Cerio, F.G.; Soler, A.; Alvarez-Diaz, F.J. Hypoxic-ischemic injury in the immature brain-key vascular and cellular players. Neonatology, 2007, 92, 227.
21. Walton, M.; Connor, B.; Lawlor, P.; Young, D.; Sirimanne, E.; Gluckman, P., Cole, G., Dragunow, M. Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res. Brain Res. Rev., 1999, 29, 137.
22. Ferriero, D.M. Neonatal brain injury. N. Engl. J. Med., 2004, 351, 1985.
23. Sugawara, T.; Fujimura, M.; Noshita, N.; Kim, G.W.; Saito, A.; Hayashi, T.; Narasimhan, P.; Maier, C.M.; Chan, P.H. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx., 2004, 1, 17.
24. Lorek, A.; Takei, Y.; Cady, E.B.; Wyatt, J.S.; Penrice, J.; Edwards, A.D.; Peebles, D.; Wylezinska, M.; Owen-Reece, H.; Kirkbride, V. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr. Res., 1994, 36, 699.
25. Back, S.A.; Luo, N.L.; Borenstein, N.S.; Levine, J.M.; Volpe, J.J.; Kinney, H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci., 2001, 21, 1302.
26. Hilario, E.; Rey-Santano, M.C.; Goni-de-Cerio, F.; Alvarez, F.J.; Gastiasoro, E.; Mielgo, V.E.; Caballero, A.; Soler, A.; Gomez-Urquijo, S.; Alvarez, A. Cerebral blood flow and morphological changes after hypoxic-ischaemic injury in preterm lambs. Acta Paediatr., 2005, 94, 903.
27. Volpe, J.J. Brain injury in the premature infant--current concepts. Prev. Med., 1994, 23, 638.
28. Rivkin, M.J. Hypoxic-ischemic brain injury in the term newborn. Neuropathology, clinical aspects, and neuroimaging. Clin. Perinatol., 1997, 24, 607.
29. Volpe, J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res., 2001, 50, 553.
30. du Plessis, A.J.; Volpe, J.J. Perinatal brain injury in the preterm and term newborn. Curr. Opin. Neurol., 2002, 15, 151.
31. Berger, R.; Garnier, Y. Perinatal brain injury. J. Perinat. Med., 2000, 28, 261.
32. Johnston, M.V.; Trescher, W.H.; Ishida, A.; Nakajima, W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res., 2001, 49, 735.
33. Halterman, M.W.; Miller, C.C.; Federoff, H.J. Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J. Neurosci., 1999, 19, 6818.
34. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev., 2002, 82, 47.
35. Jensen, A.; Garnier, Y.; Middelanis, J.; Berger, R. Perinatal brain damage-from pathophysiology to prevention. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 110(Suppl. 1), S70-S79.
36. Buonocore, G.; Perrone, S. Biomarkers of hypoxic brain injury in the neonate. Clin. Perinatol., 2004, 31, 107.
37. Fern, R.; Moller, T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci., 2000, 20, 34.
38. Palmer, C.; Towfighi, J.; Roberts, R.L.; Heitjan, D.F. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr. Res., 1993, 33, 405.
39. Hamada, Y.; Hayakawa, T.; Hattori, H.; Mikawa, H. Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr. Res., 1994, 35, 10.
40. Patkai, J.; Mesples, B.; Dommergues, M.A.; Fromont, G.; Thornton, E.M.; Renauld, J.C.; Evrard, P.; Gressens, P. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr. Res., 2001, 50, 222.
41. Kristian, T. Metabolic stages, mitochondria and calcium in hypoxic/ ischemic brain damage. Cell Calcium, 2004, 36, 221.
42. Englund, E. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc. Dis., 2002, 13(Suppl. 2), 11.
43. Counsell, S.J.; Rutherford, M.A.; Cowan, F.M.; Edwards, A.D. Magnetic resonance imaging of preterm brain injury. Arch. Dis. Child Fetal Neonatal Ed., 2003, 88, F269-F274.
44. Peterson, B.S. Brain imaging studies of the anatomical and functional consequences of preterm birth for human brain development. Ann. N Y Acad. Sci., 2003, 1008, 219.
45. McQuillen, P.S.; Ferriero, D.M. Selective vulnerability in the developing central nervous system. Pediatr. Neurol., 2004, 30, 227.
46. Russ, A.; Hand, I.L. Preterm brain injury: imaging and neurodevelopmental outcome. Am. J. Perinatol., 2004, 21, 167.
47. Perlman, J.M. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: medicolegal issues. Pediatrics, 1997, 99, 851.
48. Wyatt, J.S.; Edwards, A.D.; Azzopardi, D.; Reynolds, E.O. Magnetic resonance and near infrared spectroscopy for investigation of perinatal hypoxic-ischaemic brain injury. Arch. Dis. Child, 1989, 64, 953.
49. Ellis, E.F.; Willoughby, K.A.; Sparks, S.A.; Chen, T. S100B protein is released from rat neonatal neurons, astrocytes, and microglia by in vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons. J. Neurochem., 2007, 101, 1463.
50. Adami, C.; Bianchi, R.; Pula, G.; Donato, R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta, 2004, 1742, 169.
51. Tasaka, K.; Kasahara, K.; Masumoto, N.; Mizuki, J.; Kurachi, H.; Miyake, A.; Tanizawa, O. Activin A increases cytosolic free calcium concentration in rat pituitary somatotropes. Biochem. Biophys. Res. Commun., 1992, 185, 974.
52. Jauch, E.C.; Lindsell, C.; Broderick, J.; Fagan, S.C.; Tilley, B.C.; Levine, S.R. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke, 2006, 37, 2508.
53. Grow, J.; Barks, J.D. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts. Clin. Perinatol., 2002, 29, 585, v.
54. Ji, S.M.; Xue, J.M.; Wang, C.; Su, S.W.; He, R.R. Adrenomedullin reduces intracellular calcium concentration in cultured hippocampal neurons. Sheng Li Xue. Bao., 2005, 57, 340.
55. Roth, S.C.; Baudin, J.; Cady, E.; Johal, K.; Townsend, J.P.; Wyatt, J.S.; Reynolds, E.O.; Stewart, A.L. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev. Med. Child Neurol., 1997, 39, 718.
56. Palmer, C. Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. Clin. Perinatol., 1995, 22, 481.
57. Magistretti, P.J.; Pellerin, L.; Rothman, D.L.; Shulman, R.G. Energy on demand. Science, 1999, 283, 496.
58. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1988, 1, 623.
59. Minc-Golomb, D.; Levy, Y.; Kleinberger, N.; Schramm, M. D-[3H]aspartate release from hippocampus slices studied in a multiwell system: controlling factors and postnatal development of release. Brain Res., 1987, 402, 255.
60. Hagberg, H.; Andersson, P.; Kjellmer, I.; Thiringer, K.; Thordstein, M. Extracellular overflow of glutamate, aspartate, GABA and taurine in the cortex and basal ganglia of fetal lambs during hypoxia-ischemia. Neurosci. Lett., 1987, 78, 311.
61. Danbolt, N.C. Glutamate uptake. Prog. Neurobiol., 2001, 65, 1.
62. Mishra, O.P.; Delivoria-Papadopoulos, M. Cellular mechanisms of hypoxic injury in the developing brain. Brain Res. Bull., 1999, 48, 233.
63. Fox, K.; Schlaggar, B.L.; Glazewski, S.; O'Leary, D.D. Glutamate receptor blockade at cortical synapses disrupts development of thalamocortical and columnar organization in somatosensory cortex. Proc. Natl. Acad. Sci. USA, 1996, 93, 5584.
64. Sibson, N.R.; Shen, J.; Mason, G.F.; Rothman, D.L.; Behar, K.L.; Shulman, R.G. Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronalactivity. Dev. Neurosci., 1998, 20, 321.
65. Jabaudon, D.; Scanziani, M.; Gahwiler, B.H.; Gerber, U. Acute decrease in net glutamate uptake during energy deprivation. Proc. Natl. Acad. Sci. USA, 2000, 97, 5610.
66. Tao, F.; Lu, S.D.; Zhang, L.M.; Huang, Y.L.; Sun, F.Y. Role of excitatory amino acid transporter 1 in neonatal rat neuronal damage induced by hypoxia-ischemia. Neurosci., 2001, 102, 503.
67. Levene, M.I.; Gibson, N.A.; Fenton, A.C.; Papathoma, E.; Barnett, D. The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev. Med. Child Neurol., 1990, 32, 567.
68. Mishra, O.P.; Delivoria-Papadopoulos, M. Lipid peroxidation in developing fetal guinea pig brain during normoxia and hypoxia. Brain Res. Dev. Brain Res., 1989, 45, 129.
69. Crawford, M.A.; Sinclair, A.J. Nutritional influences in the evolution of mammalian brain. In: lipids, malnutrition & the developing brain. Ciba Found. Symp., 1971, 267, 92.
70. Maulik, D.; Numagami, Y.; Ohnishi, S.T.; Mishra, O.P.; Delivoria-Papadopoulos, M. Direct measurement of oxygen free radicals during in utero hypoxia in the fetal guinea pig brain. Brain Res., 1998, 798, 166.
71. Khan, J.Y.; Black, S.M. Developmental changes in murine brain antioxidant enzymes. Pediatr. Res., 2003, 54, 77.
72. Ferriero, D.M. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev. Neurosci., 2001, 23, 198.
73. van Bel, F.; Roman, C.; Klautz, R.J.; Teitel, D.F.; Rudolph, A.M. Relationship between brain blood flow and carotid arterial flow in the sheep fetus. Pediatr. Res., 1994, 35, 329.
74. Ogihara, T.; Hirano, K.; Ogihara, H.; Misaki, K.; Hiroi, M.; Morinobu, T.; Kim, H.S.; Ogawa, S.; Ban, R.; Hasegawa, M.; Tamai, H. Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy. Pediatr. Res., 2003, 53, 594.
75. Subbarao, K.V.; Richardson, J.S. Iron-dependent peroxidation of rat brain: a regional study. J. Neurosci. Res., 1990, 26, 224.
76. Almli, L.M.; Hamrick, S.E.; Koshy, A.A.; Tauber, M.G.; Ferriero, D.M. Multiple pathways of neuroprotection against oxidative stress and excitotoxic injury in immature primary hippocampal neurons. Brain Res. Dev. Brain Res., 2001, 132, 121.
77. Sarco, D.P.; Becker, J.; Palmer, C.; Sheldon, R.A.; Ferriero, D.M. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain. Neurosci. Lett., 2000, 282, 113.
78. McLean, C.W.; Mirochnitchenko, O.; Claus, C.P.; Noble-Haeusslein, L.J.; Ferriero, D.M. Overexpression of glutathione peroxidase protects immature murine neurons from oxidative stress. Dev. Neurosci., 2005, 27, 169.
79. Fullerton, H.J.; Ditelberg, J.S.; Chen, S.F.; Sarco, D.P.; Chan, P.H.; Epstein, C.J.; Ferriero, D.M. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann. Neurol., 1998, 44, 357.
80. Yue, T.L.; Gu, J.L.; Lysko, P.G.; Cheng, H.Y.; Barone, F.C.; Feuerstein, G. Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res., 1992, 574, 193.
81. Cao, X.; Phillis, J.W. alpha-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res., 1994, 644, 267.
82. Sorrentino, D.F.; Fritz, K.I.; Haider, S.H.; Parikh, N.; Papadopoulos, M.D.; Mishra, O.P. Nitric oxide-mediated modification of the glycine binding site of the NMDA receptor during hypoxia in the cerebral cortex of the newborn piglet. Neurochem. Res., 2004, 29, 455.
83. Ferriero, D.M.; Holtzman, D.M.; Black, S.M.; Sheldon, R.A. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol. Dis., 1996, 3, 64.
84. Black, S.M.; Bedolli, M.A.; Martinez, S.; Bristow, J.D.; Ferriero, D.M.; Soifer, S.J. Expression of neuronal nitric oxide synthase corresponds to regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol. Dis., 1995, 2, 145.
85. Ishida, A.; Trescher, W.H.; Lange, M.S.; Johnston, M.V. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev., 2001, 23, 349.
86. Peeters-Scholte, C.; Koster, J.; van den, T.E.; Blomgren, K.; Hamers, N.; Zhu, C.; Buul-Offers, S.; Hagberg, H.; van Bel, F.; Heijnen, C.; Groenendaal, F. Effects of selective nitric oxide synthase inhibition on IGF-1, caspases and cytokines in a newborn piglet model of perinatal hypoxia-ischaemia. Dev. Neurosci., 2002, 24, 396.
87. Parikh, N.A.; Katsetos, C.D.; Ashraf, Q.M.; Haider, S.H.; Legido, A.; Delivoria-Papadopoulos, M.; Mishra, O.P. Hypoxia-induced caspase-3 activation and DNA fragmentation in cortical neurons of newborn piglets: role of nitric oxide. Neurochem. Res., 2003, 28, 1351.
88. Mishra, O.P.; Zubrow, A.B.; Ashraf, Q.M. Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets. Neurosci., 2004, 123, 179.
89. Harris, C.; Maroney, A.C.; Johnson, E.M., Jr. Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis. J. Neurochem., 2002, 83, 992.
90. Wang, X.; Zhu, C.; Qiu, L.; Hagberg, H.; Sandberg, M.; Blomgren, K. Activation of ERK1/2 after neonatal rat cerebral hypoxia-ischaemia. J. Neurochem., 2003, 86, 351.
91. Dammann, O.; Leviton, A. Role of the fetus in perinatal infection and neonatal brain damage. Curr. Opin. Pediatr., 2000, 12, 99.
92. Savman, K.; Blennow, M.; Gustafson, K.; Tarkowski, E.; Hagberg, H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr. Res., 1998, 43, 746.
93. Foster-Barber, A.; Ferriero, D.M. Neonatal encephalopathy in the term infant: neuroimaging and inflammatory cytokines. Ment. Retard. Dev. Disabil. Res. Rev., 2002, 8, 20.
94. Wood, P.L. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol. Res., 1995, 17, 242.
95. Tahraoui, S.L.; Marret, S.; Bodenant, C.; Leroux, P.; Dommergues, M.A.; Evrard, P.; Gressens, P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol., 2001, 11, 56.
96. Dommergues, M.A.; Plaisant, F.; Verney, C.; Gressens, P. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neurosci., 2003, 121, 619.
97. Sheldon, R.A.; Sedik, C.; Ferriero, D.M. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res., 1998, 810, 114.
98. Yonekura, I.; Kawahara, N.; Nakatomi, H.; Furuya, K.; Kirino, T. A model of global cerebral ischemia in C57 BL/6 mice. J. Cereb. Blood Flow Metab., 2004, 24, 151.
99. Banasiak, K.J.; Xia, Y.; Haddad, G.G. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog. Neurobiol., 2000, 62, 215.
100. Szolnoki, Z.; Somogyvari, F.; Kondacs, A.; Szabo, M.; Fodor, L. Evaluation of the interactions of common genetic mutations in stroke subtypes. J. Neurol., 2002, 249, 1391.
101. Gunther, G.; Junker, R.; Strater, R.; Schobess, R.; Kurnik, K.; Heller, C.; Kosch, A.; Nowak-Gottl, U. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke, 2000, 31, 2437.
102. Nunez, J.L.; McCarthy, M.M. Sex differences and hormonal effects in a model of preterm infant brain injury. Ann. NY Acad. Sci., 2003, 1008, 281.
103. Schurr, A. Lactate, glucose and energy metabolism in the ischemic brain (Review]. Int. J. Mol. Med., 2002, 10, 131.
104. Arrica, M.; Bissonnette, B. Therapeutic hypothermia. Semin. Cardiothorac. Vasc. Anesth., 2007, 11, 6.
105. Ren, Z.; Ding, W.; Su, Z.; Gu, X.; Huang, H.; Liu, J.; Yan, Q.; Zhang, W.; Yu, X. Mechanisms of brain injury with deep hypothermic circulatory arrest and protective effects of coenzyme Q10. J. Thorac. Cardiovasc. Surg., 1994, 108, 126.
106. Kawata, H.; Fackler, J.C.; Aoki, M.; Tsuji, M.K.; Sawatari, K.; Offutt, M.; Hickey, P.R.; Holtzman, D.; Jonas, R.A. Recovery of cerebral blood flow and energy state in piglets after hypothermic circulatory arrest versus recovery after low-flow bypass. J. Thorac. Cardiovasc. Surg., 1993, 106, 671.
107. Berliocchi, L.; Bano, D.; Nicotera, P. Ca2+ signals and death programmes in neurons. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2005, 360, 2255.
108. De Somer, F. Impact of oxygenator characteristics on its capability to remove gaseous microemboli. J. Extra Corpor. Technol., 2007, 39, 271.
109. Taylor, R.L.; Borger, M.A.; Weisel, R.D.; Fedorko, L.; Feindel, C.M. Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann. Thorac. Surg., 1999, 68, 89.
110. Prasongsukarn, K.; Borger, M.A. Reducing cerebral emboli during cardiopulmonary bypass. Semin. Cardiothorac. Vasc. Anesth., 2005, 9, 153.
111. Geissler, H.J.; Allen, S.J.; Mehlhorn, U.; Davis, K.L.; de Vivie, E.R.; Kurusz, M.; Butler, B.D. Cooling gradients and formation of gaseous microemboli with cardiopulmonary bypass: an echocardiographic study. Ann. Thorac. Surg., 1997, 64, 100.
112. Rubens, F.D.; Mesana, T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion, 2004, 19(Suppl. 1), S5.
113. Alcaraz, A.J.; Manzano, L.; Sancho, L.; Vigil, M.D.; Esquivel, F.; Maroto, E.; Reyes, E.; Alvarez-Mon, M. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J. Clin. Immunol., 2005, 25, 238.
114. Kerendi, F.; Halkos, M.E.; Kin, H.; Corvera, J.S.; Brat, D.J.; Wagner, M.B.; Vinten-Johansen, J.; Zhao, Z.Q.; Forbess, J.M.; Kanter, K.R.; Kelley, M.E.; Kirshbom, P.M. Upregulation of hypoxia inducible factor is associated with attenuation of neuronal injury in neonatal piglets undergoing deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg., 2005, 130, 1079.
115. Ashraf, S.; Tian, Y.; Cowan, D.; Entress, A.; Martin, P.G.; Watterson, K.G. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators. Ann. Thorac. Surg., 1997, 64, 1790.
116. Heyer, E.J.; Lee, K.S.; Manspeizer, H.E.; Mongero, L.; Spanier, T.B.; Caliste, X.; Esrig, B.; Smith, C. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J. Cardiothorac. Vasc. Anesth., 2002, 16, 37.
117. Shum-Tim, D.; Tchervenkov, C.I.; Jamal, A.M.; Nimeh, T.; Luo, C.Y.; Chedrawy, E.; Laliberte, E.; Philip, A.; Rose, C.P.; Lavoie, J. Systemic steroid pretreatment improves cerebral protection after circulatory arrest. Ann. Thorac. Surg., 2001, 72, 1465.
118. El Azab, S.R.; Rosseel, P.M.; de Lange, J.J.; Groeneveld, A.B.; van Strik, R.; van Wijk, E.M.; Scheffer, G.J. Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery. Br. J. Anaesth., 2002, 88, 496.
119. Simon, N.P. Long-term neurodevelopmental outcome of asphyxiated newborns. Clin. Perinatol., 1999, 26, 767.
120. Crack, P.J.; Taylor, J.M. Reactive oxygen species and the modulation of stroke. Free Radic. Biol. Med., 2005, 38, 1433.
121. Luisi, S.; Florio, P.; Reis, F.M.; Petraglia, F. Expression and secretion of activin A: possible physiological and clinical implications. Eur. J. Endocrinol., 2001, 145, 225.
122. Florio, P.; Abella, R.F.; de la, T.T.; Giamberti, A.; Luisi, S.; Butera, G.; Cazzaniga, A.; Frigiola, A.; Petraglia, F.; Gazzolo, D. Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. Clin. Chem., 2007, 53, 982.
123. Florio, P.; Gazzolo, D.; Luisi, S.; Petraglia, F. Activin A in brain injury. Adv. Clin. Chem., 2007, 43, 117.
124. Lai, M.; Sirimanne, E.; Williams, C.E.; Gluckman, P.D. Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. Neurosci., 1996, 70, 1013.
125. Wu, D.D.; Lai, M.; Hughes, P.E.; Sirimanne, E.; Gluckman, P.D.; Williams, C.E. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res., 1999, 835, 369.
126. Florio, P.; Gazzolo, D.; Luisi, S.; Petraglia, F. Activin A in brain injury. Adv. Clin. Chem., 2007, 43, 117.
127. Schubert, D.; Kimura, H.; LaCorbiere, M.; Vaughan, J.; Karr, D.; Fischer, W.H. Activin is a nerve cell survival molecule. Nature, 1990, 344, 868.
128. Krieglstein, K.; Suter-Crazzolara, C.; Fischer, W.H.; Unsicker, K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J., 1995, 14, 736.
129. Iwahori, Y.; Saito, H.; Torii, K.; Nishiyama, N. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res., 1997, 760, 52.
130. Hughes, P.E.; Alexi, T.; Williams, C.E.; Clark, R.G.; Gluckman, P.D. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neurosci., 1999, 92, 197.
131. Florio, P.; Perrone, S.; Luisi, S.; Vezzosi, P.; Longini, M.; Marzocchi, B.; Petraglia, F.; Buonocore, G. Increased plasma concentrations of activin a predict intraventricular hemorrhage in preterm newborns. Clin. Chem., 2006, 52, 1516.
132. Florio, P.; Luisi, S.; Bruschettini, M.; Grutzfeld, D.; Dobrzanska, A.; Bruschettini, P.; Petraglia, F.; Gazzolo, D. Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin. Chem., 2004, 50, 2386.
133. Florio, P.; Luisi, S.; Moataza, B.; Torricelli, M.; Iman, I.; Hala, M.; Hanna, A.; Petraglia, F.; Gazzolo, D. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Clin. Chem., 2007, 53, 520.
134. Florio, P.; Felipe, A.R.; de la, T.T.; Giamberti, A.; Luisi, S.; Bufera, G.; Cazzaniga, A.; Frigiola, A.; Petraglia, F.; Gazzolo, D. Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery. Clin. Chem., 2007, 53, 982.
135. Rickmann, M.; Wolff, J.R. S100 protein expression in subpopulations of neurons of rat brain. Neurosci., 1995, 67, 977.
136. Yang, Q.; Hamberger, A.; Hyden, H.; Wang, S.; Stigbrand, T.; Haglid, K.G. S-100 beta has a neuronal localisation in the rat hind-brain revealed by an antigen retrieval method. Brain Res., 1995, 696, 49.
137. Haimoto, H.; Hosoda, S.; Kato, K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal non-nervous human tissues. Lab Invest., 1987, 57, 489.
138. Michetti, F.; Dell'Anna, E.; Tiberio, G.; Cocchia, D. Immunochemical and immunocytochemical study of S-100 protein in rat adipocytes. Brain Res., 1983, 262, 352.
139. Buyukuysal, R.L. Protein S100B release from rat brain slices during and after ischemia: comparison with lactate dehydrogenase leakage. Neurochem. Int., 2005, 47, 580.
140. Gerlach, R.; Demel, G.; Konig, H.G.; Gross, U.; Prehn, J.H.; Raabe, A.; Seifert, V.; Kogel, D. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience, 2006, 141, 1697.
141. Abraha, H.D.; Butterworth, R.J.; Bath, P.M.; Wassif, W.S.; Garthwaite, J.; Sherwood, R.A. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann. Clin. Biochem., 1997, 34(Pt 5), 546.
142. Kanner, A.A.; Marchi, N.; Fazio, V.; Mayberg, M.R.; Koltz, M.T.; Siomin, V.; Stevens, G.H.; Masaryk, T.; Aumayr, B.; Vogelbaum, M.A.; Barnett, G.H.; Janigro, D. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer, 2003, 97, 2806.
143. Hu, J.; Castets, F.; Guevara, J.L.; Van Eldik, L.J. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem., 1996, 271, 2543.
144. Aurell, A.; Rosengren, L.E.; Karlsson, B.; Olsson, J.E.; Zbornikova, V.; Haglid, K.G. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke, 1991, 22, 1254.
145. Wakita, H.; Tomimoto, H.; Akiguchi, I.; Kimura, J. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol., 1994, 87, 484.
146. Tomimoto, H.; Ihara, M.; Wakita, H.; Ohtani, R.; Lin, J.X.; Akiguchi, I.; Kinoshita, M.; Shibasaki, H. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol., 2003, 106, 527.
147. Ueno, M.; Tomimoto, H.; Akiguchi, I.; Wakita, H.; Sakamoto, H. Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J. Cereb. Blood Flow Metab., 2002, 22, 97.
148. Nawashiro, H.; Brenner, M.; Fukui, S.; Shima, K.; Hallenbeck, J.M. High susceptibility to cerebral ischemia in GFAP-null mice. J. Cereb. Blood Flow Metab., 2000, 20, 1040.
149. Guo, L.; Sawkar, A.; Zasadzki, M.; Watterson, D.M.; Van Eldik, L.J. Similar activation of glial cultures from different rat brain regions by neuroinflammatory stimuli and downregulation of the activation by a new class of small molecule ligands. Neurobiol. Aging, 2001, 22, 975.
150. Murphy, S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia, 2000, 29, 1.
151. Lam, A.G.; Koppal, T.; Akama, K.T.; Guo, L.; Craft, J.M.; Samy, B.; Schavocky, J.P.; Watterson, D.M.; Van Eldik, L.J. Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol. Aging, 2001, 22, 765.
152. Sharp, F.R.; Lu, A.; Tang, Y.; Millhorn, D.E. Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab., 2000, 20, 1011.
153. Asano, T.; Mori, T.; Shimoda, T.; Shinagawa, R.; Satoh, S.; Yada, N.; Katsumata, S.; Matsuda, S.; Kagamiishi, Y.; Tateishi, N. Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B. Curr. Drug Targets CNS Neurol. Disord., 2005, 4, 127.
154. Matsui, T.; Mori, T.; Tateishi, N.; Kagamiishi, Y.; Satoh, S.; Katsube, N.; Morikawa, E.; Morimoto, T.; Ikuta, F.; Asano, T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion. J. Cereb. Blood Flow Metab., 2002, 22, 711.
155. Ohtani, R.; Tomimoto, H.; Wakita, H.; Kitaguchi, H.; Nakaji, K.; Takahashi, R. Expression of S100 protein and protective effect of arundic acid on the rat brain in chronic cerebral hypoperfusion. Brain Res., 2007, 1135, 195.
156. Michetti, F.; Gazzolo, D. S100B testing in pregnancy. Clin. Chim. Acta, 2003, 335, 1.
157. Michetti, F.; Massaro, A.; Murazio, M. The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci. Lett., 1979, 11, 171.
158. Michetti, F.; Massaro, A.; Russo, G.; Rigon, G. The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system. J. Neurol. Sci., 1980, 44, 259.
159. Whitelaw, A.; Rosengren, L.; Blennow, M. Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch. Dis. Child Fetal Neonatal Ed., 2001, 84, F90-F91.
160. Blennow, M.; Savman, K.; Ilves, P.; Thoresen, M.; Rosengren, L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr., 2001, 90, 1171.
161. Sellman, M.; Ivert, T.; Ronquist, G.; Caesarini, K.; Persson, L.; Semb, B.K. Central nervous system damage during cardiac surgery assessed by 3 different biochemical markers in cerebrospinal fluid. Scand. J. Thorac. Cardiovasc. Surg., 1992, 26, 39.
162. Persson, L.; Hardemark, H.G.; Gustafsson, J.; Rundstrom, G.; Mendel-Hartvig, I.; Esscher, T.; Pahlman, S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke, 1987, 18, 911.
163. Gazzolo, D.; Vinesi, P.; Bartocci, M.; Geloso, M.C.; Bonacci, W.; Serra, G.; Haglid, K.G.; Michetti, F. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J. Neurol. Sci., 1999, 170, 32.
164. Gazzolo, D.; di Iorio, R.; Marinoni, E.; Masetti, P.; Serra, G.; Giovannini, L.; Michetti, F. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit. Care Med., 2002, 30, 1356.
165. Nagdyman, N.; Komen, W.; Ko, H.K.; Muller, C.; Obladen, M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr. Res., 2001, 49, 502.
166. Gazzolo, D.; Masetti, P.; Meli, M.; Grutzfeld, D.; Michetti, F. Elevated S100B protein as an early indicator of intracranial haemorrhage in infants subjected to extracorporeal membrane oxygenation. Acta Paediatr., 2002, 91, 218.
167. Golej, J.; Trittenwein, G. Early detection of neurologic injury and issues of rehabilitation after pediatric cardiac extracorporeal membrane oxygenation. Artif. Organs, 1999, 23, 1020.
168. Gazzolo, D.; Marinoni, E.; di Iorio, R.; Lituania, M.; Bruschettini, P.L.; Michetti, F. Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr. Res., 2002, 51, 215.
169. Gazzolo, D.; Marinoni, E.; di Iorio, R.; Lituania, M.; Marras, M.; Bruschettini, M.; Bruschettini, P.; Frulio, R.; Michetti, F.; Petraglia, F.; Florio, P. High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular
170. Gazzolo, D.; Bruschettini, M.; Lituania, M.; Serra, G.; Gandullia, E.; Michetti, F. S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin. Chem., 2001, 47, 1132.
171. Gazzolo, D.; Bruschettini, M.; Lituania, M.; Serra, G.; Bonacci, W.; Michetti, F. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin. Chem., 2001, 47, 1836.
172. Gazzolo, D.; Marinoni, E.; di Iorio, R.; Bruschettini, M.; Kornacka, M.; Lituania, M.; Majewska, U.; Serra, G.; Michetti, F. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch. Pediatr. Adolesc. Med., 2003, 157, 1163.
173. Hinson, J.P.; Kapas, S.; Smith, D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev., 2000, 21, 138.
174. Kitamura, K.; Kangawa, K.; Kawamoto, M.; Ichiki, Y.; Nakamura, S.; Matsuo, H.; Eto, T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun., 1993, 192, 553.
175. Allen, M.A.; Ferguson, A.V. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am. J. Physiol., 1996, 270, R920-R925.
176. Kato, H.; Shichiri, M.; Marumo, F.; Hirata, Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology, 1997, 138, 2615.
177. Oehler, M.K.; Norbury, C.; Hague, S.; Rees, M.C.; Bicknell, R. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene, 2001, 20, 2937.
178. Wang, X.; Yue, T.L.; Barone, F.C.; White, R.F.; Clark, R.K.; Willette, R.N.; Sulpizio, A.C.; Aiyar, N.V.; Ruffolo, R.R., Jr.; Feuerstein, G.Z. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc. Natl. Acad. Sci. USA, 1995, 92, 11480.
179. Nagata, D.; Hirata, Y.; Suzuki, E.; Kakoki, M.; Hayakawa, H.; Goto, A.; Ishimitsu, T.; Minamino, N.; Ono, Y.; Kangawa, K.; Matsuo, H.; Omata, M. Hypoxia-induced adrenomedullin production in the kidney. Kidney Int., 1999, 55, 1259.
180. Ueda, S.; Nishio, K.; Minamino, N.; Kubo, A.; Akai, Y.; Kangawa, K.; Matsuo, H.; Fujimura, Y.; Yoshioka, A.; Masui, K.; Doi, N.; Murao, Y.; Miyamoto, S. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am. J. Respir. Crit. Care Med., 1999, 160, 132.
181. Caron, K.M.; Smithies, O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc. Natl. Acad. Sci. USA, 2001, 98, 615.
182. Shimosawa, T.; Shibagaki, Y.; Ishibashi, K.; Kitamura, K.; Kangawa, K.; Kato, S.; Ando, K.; Fujita, T. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation, 2002, 105, 106.
183. Shindo, T.; Kurihara, Y.; Nishimatsu, H.; Moriyama, N.; Kakoki, M.; Wang, Y.; Imai, Y.; Ebihara, A.; Kuwaki, T.; Ju, K.H.; Minamino, N.; Kangawa, K.; Ishikawa, T.; Fukuda, M.; Akimoto, Y.; Kawakami, H.; Imai, T.; Morita, H.; Yazaki, Y.; Nagai, R.; Hirata, Y.; Kurihara, H. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation, 2001, 104, 1964.
184. Ueta, Y.; Kitamura, K.; Isse, T.; Shibuya, I.; Kabashima, N.; Yamamoto, S.; Kangawa, K.; Matsuo, H.; Eto, T.; Yamashita, H. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci. Lett., 1995, 202, 37.
185. Satoh, F.; Takahashi, K.; Murakami, O.; Totsune, K.; Sone, M.; Ohneda, M.; Sasano, H.; Mouri, T. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci. Lett., 1996, 203, 207.
186. Garayoa, M.; Martinez, A.; Lee, S.; Pio, R.; An, W.G.; Neckers, L.; Trepel, J.; Montuenga, L.M.; Ryan, H.; Johnson, R.; Gassmann, M.; Cuttitta, F. Hypoxia-inducible factor-1 [HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol. Endocrinol., 2000, 14, 848.
187. Serrano, J.; Alonso, D.; Encinas, J.M.; Lopez, J.C.; Fernandez, A.P.; Castro-Blanco, S.; Fernandez-Vizarra, P.; Richart, A.; Bentura, M.L.; Santacana, M.; Uttenthal, L.O.; Cuttitta, F.; Rodrigo, J.; Martinez, A. Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neurosci., 2002, 109, 717.
188. Encinas, J.M.; Serrano, J.; Alonso, D.; Fernandez, A.P.; Rodrigo, J. Adrenomedullin over-expression in the caudate-putamen of the adult rat brain after ischaemia-reperfusion injury. Neurosci. Lett., 2002, 329, 197.
189. Bernaudin, M.; Tang, Y.; Reilly, M.; Petit, E.; Sharp, F.R. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J. Biol. Chem., 2002, 277, 39728.
190. Serrano, J.; Alonso, D.; Fernandez, A.P.; Encinas, J.M.; Lopez, J.C.; Castro-Blanco, S.; Fernandez-Vizarra, P.; Richart, A.; Santacana, M.; Uttenthal, L.O.; Bentura, M.L.; Martinez-Murillo, R.; Martinez, A.; Cuttitta, F.; Rodrigo, J. Adrenomedullin in the central nervous system. Microsc. Res. Tech., 2002, 57, 76.
191. Dogan, A.; Suzuki, Y.; Koketsu, N.; Osuka, K.; Saito, K.; Takayasu, M.; Shibuya, M.; Yoshida, J. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab., 1997, 17, 19.
192. Watanabe, K.; Takayasu, M.; Noda, A.; Hara, M.; Takagi, T.; Suzuki, Y.; Yoshia, J. Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats. Acta Neurochir. (Wien.), 2001, 143, 1157.
193. Xia, C.F.; Yin, H.; Borlongan, C.V.; Chao, J.; Chao, L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum. Gene Ther., 2004, 15, 1243.
194. Miyashita, K.; Itoh, H.; Arai, H.; Suganami, T.; Sawada, N.; Fukunaga, Y.; Sone, M.; Yamahara, K.; Yurugi-Kobayashi, T.; Park, K.; Oyamada, N.; Sawada, N.; Taura, D.; Tsujimoto, H.; Chao, T.H.; Tamura, N.; Mukoyama, M.; Nakao, K. The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. Endocrinology, 2006, 147, 1642.
195. Boldt, T.; Luukkainen, P.; Fyhrquist, F.; Pohjavuori, M.; Andersson, S. Birth stress increases adrenomedullin in the newborn. Acta Paediatr., 1998, 87, 93.
196. de Vroomen, M.; Takahashi, Y.; Gournay, V.; Roman, C.; Rudolph, A.M.; Heymann, M.A. Adrenomedullin increases pulmonary blood flow in fetal sheep. Pediatr. Res., 1997, 41, 493.
197. Yamashiro, C.; Hayashi, K.; Yanagihara, T.; Hata, T. Plasma adrenomedullin levels in pregnancies with appropriate for gestational age and small for gestational age infants. J. Perinat. Med., 2001, 29, 513.
198. Akturk, A.; Onal, E.E.; Atalay, Y.; Yurekli, M.; Erbas, D.; Okumus, N.; Turkyilmaz, C.; Unal, S.; Ergenekon, E.; Koc, E.; Himmetoglu, O. Maternal and umbilical venous adrenomedullin and nitric oxide levels in intrauterine growth restriction. J. Matern. Fetal Neonatal Med., 2007, 20, 521.
199. Trollmann, R.; Schoof, E.; Beinder, E.; Wenzel, D.; Rascher, W.; Dotsch, J. Adrenomedullin gene expression in human placental tIssue and leukocytes: a potential marker of severe tIssue hypoxia in neonates with birth asphyxia. Eur. J. Endocrinol., 2002, 147, 711.
200. di Iorio, R.; Marinoni, E.; Lituania, M.; Serra, G.; Letizia, C.; Cosmi, E.V.; Gazzolo, D. Adrenomedullin increases in term asphyxiated newborns developing intraventricular hemorrhage. Clin. Biochem., 2004, 37, 1112.
201. Florio, P.; Abella, R.; Marinoni, E.; di Iorio, R.; Letizia, C.; Meli, M.; de la, T.T.; Petraglia, F.; Cazzaniga, A.; Giamberti, A.; Frigiola, A.; Gazzolo, D. Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin. Chem., 2008, 54, 202.
202. Pahlman, S.; Esscher, T.; Bergvall, P.; Odelstad, L. Purification and characterization of human neuron-specific enolase: radioimmunoassay development. Tumour Biol., 1984, 5, 127.
203. Iwanaga, T.; Takahashi, Y.; Fujita, T. Immunohistochemistry of neuron-specific and glia-specific proteins. Arch. Histol. Cytol. 1989, 52(Suppl.), 13.
204. Barone, F.C.; Clark, R.K.; Price, W.J.; White, R.F.; Feuerstein, G.Z.; Storer, B.L.; Ohlstein, E.H. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res., 1993, 623, 77.
205. Ekmektzoglou, K.A.; Xanthos, T.; Papadimitriou, L. Biochemical markers (NSE, S-100, IL-8) as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation. Resuscitation, 2007, 75, 219.
206. Lamers, K.J.; Vos, P.; Verbeek, M.M.; Rosmalen, F.; van Geel, W.J.; van Engelen, B.G. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res. Bull., 2003, 61, 261.
207. Johnsson, P.; Blomquist, S.; Luhrs, C.; Malmkvist, G.; Alling, C.; Solem, J.O.; Stahl, E. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann. Thorac. Surg., 2000, 69, 750.
208. Ramont, L.; Thoannes, H.; Volondat, A.; Chastang, F.; Millet, M.C.; Maquart, F.X. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin. Chem. Lab Med., 2005, 43, 1215.
209. Takei, N.; Kondo, J.; Nagaike, K.; Ohsawa, K.; Kato, K.; Kohsaka, S. Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J. Neurochem., 1991, 57, 1178.
210. Hattori, T.; Ohsawa, K.; Mizuno, Y.; Kato, K.; Kohsaka, S. Synthetic peptide corresponding to 30 amino acids of the C-terminal of neuron-specific enolase promotes survival of neocortical neurons in culture. Biochem. Biophys. Res. Commun., 1994, 202, 25.
211. Hattori, T.; Takei, N.; Mizuno, Y.; Kato, K.; Kohsaka, S. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci. Res., 1995, 21, 191.
212. de Herder, W.W. Biochemistry of neuroendocrine tumours. Best Pract. Res. Clin. Endocrinol. Metab., 2007, 21, 33.
213. Thornberg, E.; Thiringer, K.; Hagberg, H.; Kjellmer, I. Neuron specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace. Arch. Dis. Child Fetal Neonatal Ed., 1995, 72, F39-F42.
214. Garcia-Alix, A.; Cabanas, F.; Pellicer, A.; Hernanz, A.; Stiris, T.A.; Quero, J. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants. Pediatrics, 1994, 93, 234.
215. Ezgu, F.S.; Atalay, Y.; Gucuyener, K.; Tunc, S.; Koc, E.; Ergenekon, E.; Tiras, U. Neuron-specific enolase levels and neuroimaging in asphyxiated term newborns. J. Child Neurol., 2002, 17, 824.
216. Celtik, C.; Acunas, B.; Oner, N.; Pala, O. Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy. Brain Dev., 2004, 26, 398.
217. Nagdyman, N.; Grimmer, I.; Scholz, T.; Muller, C.; Obladen, M. Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr. Res., 2003, 54, 270.
218. Schmitt, B.; Bauersfeld, U.; Schmid, E.R.; Tuchschmid, P.; Molinari, L.; Fanconi, S.; Bandtlow, C. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Brain Dev., 1998, 20, 536.
219. Nedergaard, M.; Dirnagl, U. Role of glial cells in cerebral ischemia. Glia, 2005, 50, 281.
220. Panickar, K.S.; Norenberg, M.D. Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia, 2005, 50, 287.
221. Plum, F. What causes infarction in ischemic brain?: The Robert Wartenberg Lecture. Neurology, 1983, 33, 222.
222. Garcia, J.H.; Yoshida, Y.; Chen, H.; Li, Y.; Zhang, Z.G.; Lian, J.; Chen, S.; Chopp, M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am. J. Pathol., 1993, 142, 623.
223. Martin, L.J.; Brambrink, A.M.; Lehmann, C.; Portera-Cailliau, C.; Koehler, R.; Rothstein, J.; Traystman, R.J. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Ann. Neurol., 1997, 42, 335.
224. Lukaszevicz, A.C.; Sampaio, N.; Guegan, C.; Benchoua, A.; Couriaud, C.; Chevalier, E.; Sola, B.; Lacombe, P.; Onteniente, B. High sensitivity of protoplasmic cortical astroglia to focal ischemia. J. Cereb. Blood Flow Metab., 2002, 22, 289.
225. Missler, U.; Wiesmann, M.; Wittmann, G.; Magerkurth, O.; Hagenstrom, H. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin. Chem., 1999, 45, 138.
226. Pelinka, L.E.; Kroepfl, A.; Leixnering, M.; Buchinger, W.; Raabe, A.; Redl, H. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J. Neurotrauma, 2004, 21, 1553.
227. Herrmann, M.; Vos, P.; Wunderlich, M.T.; de Bruijn, C.H.; Lamers, K.J. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke, 2000, 31, 2670.
228. Yasuda, Y.; Tateishi, N.; Shimoda, T.; Satoh, S.; Ogitani, E.; Fujita, S. Relationship between S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia. Brain Res., 2004, 1021, 20.
229. Foerch, C.; Curdt, I.; Yan, B.; Dvorak, F.; Hermans, M.; Berkefeld, J.; Raabe, A.; Neumann-Haefelin, T.; Steinmetz, H.; Sitzer, M. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J. Neurol. Neurosurg. Psychiatry, 2006, 77, 181.
230. Vos, P.E.; van Gils, M.; Beems, T.; Zimmerman, C.; Verbeek, M.M. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur. J. Neurol., 2006, 13, 632.
231. Wunderlich, M.T.; Wallesch, C.W.; Goertler, M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur. J. Neurol., 2006, 13, 1118.
232. Rosengren, L.E.; Wikkelso, C.; Hagberg, L. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults. J. Neurosci. Methods, 1994, 51, 197.
233. Verbeek, M.M.; De Jong, D.; Kremer, H.P. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann. Clin. Biochem., 2003, 40, 25.
234. Norgren, N.; Sundstrom, P.; Svenningsson, A.; Rosengren, L.; Stigbrand, T.; Gunnarsson, M. Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology, 2004, 63, 1586.
235. Blennow, M.; Hagberg, H.; Rosengren, L. Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr. Res., 1995, 37, 260.
236. Blennow, M.; Rosengren, L.; Jonsson, S.; Forssberg, H.; Katz-Salamon, M.; Hagberg, H.; Hesser, U.; Lagercrantz, H. Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr., 1996, 85, 485.